AU5984196A - Treatment and prevention of prostatic disease - Google Patents

Treatment and prevention of prostatic disease

Info

Publication number
AU5984196A
AU5984196A AU59841/96A AU5984196A AU5984196A AU 5984196 A AU5984196 A AU 5984196A AU 59841/96 A AU59841/96 A AU 59841/96A AU 5984196 A AU5984196 A AU 5984196A AU 5984196 A AU5984196 A AU 5984196A
Authority
AU
Australia
Prior art keywords
prevention
treatment
prostatic disease
prostatic
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59841/96A
Inventor
Atif M. Nakhla
William Rosner
Roy G. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
St Lukes Roosevelt Hospital Center
Original Assignee
ST LUKE S ROOSEVELT HOSPITAL C
Merck and Co Inc
St Lukes Roosevelt Hospital Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ST LUKE S ROOSEVELT HOSPITAL C, Merck and Co Inc, St Lukes Roosevelt Hospital Center filed Critical ST LUKE S ROOSEVELT HOSPITAL C
Publication of AU5984196A publication Critical patent/AU5984196A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU59841/96A 1995-06-07 1996-06-05 Treatment and prevention of prostatic disease Abandoned AU5984196A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48463395A 1995-06-07 1995-06-07
US484633 1995-06-07
PCT/US1996/008873 WO1996040150A1 (en) 1995-06-07 1996-06-05 Treatment and prevention of prostatic disease

Publications (1)

Publication Number Publication Date
AU5984196A true AU5984196A (en) 1996-12-30

Family

ID=23924956

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59841/96A Abandoned AU5984196A (en) 1995-06-07 1996-06-05 Treatment and prevention of prostatic disease

Country Status (5)

Country Link
EP (1) EP0833641A4 (en)
JP (1) JPH11507050A (en)
AU (1) AU5984196A (en)
CA (1) CA2222625A1 (en)
WO (1) WO1996040150A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004002321A (en) * 2002-03-11 2004-01-08 Takeda Chem Ind Ltd Therapeutic agent for sex hormone dependent disease
WO2003075958A1 (en) 2002-03-11 2003-09-18 Takeda Chemical Industries, Ltd. Remedies for sex hormone-dependent disease
WO2004071533A1 (en) * 2003-02-14 2004-08-26 Takeda Pharmaceutical Company Limited Preparation for topical administration
WO2006081658A1 (en) * 2005-02-01 2006-08-10 The University Of British Columbia In silico screening for shbg binding ligands via pharmacophore models
US8361996B2 (en) * 2005-09-15 2013-01-29 Council Of Scientific And Industrial Research Imidazolyl substituted steroidal and indan-1-one derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2817157A1 (en) * 1978-04-17 1979-10-25 Schering Ag USE OF ANTIOESTROGEN AND ANTIGONADOTROP ACTING ANTIANDROGEN FOR PROPHYLAXIS AND THERAPY OF PROSTATE HYPERPLASIA
IN171596B (en) * 1989-06-27 1992-11-21 Cohen Michael
US5407944A (en) * 1993-02-19 1995-04-18 Goldman; Boris E. Compositions and methods for promoting hair growth
US5504074A (en) * 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents

Also Published As

Publication number Publication date
WO1996040150A1 (en) 1996-12-19
EP0833641A4 (en) 2000-04-05
CA2222625A1 (en) 1996-12-19
JPH11507050A (en) 1999-06-22
EP0833641A1 (en) 1998-04-08

Similar Documents

Publication Publication Date Title
AU7443496A (en) Treatment of migraine
AU7397094A (en) Prevention and treatment of alzheimer's disease
AU7650396A (en) Treatment and prophylaxis of osteoporosis
AU6328696A (en) Treatment of hemoglobinopathies
AU6435398A (en) Prevention and treatment of hepatocellular cancer
AU1556497A (en) Agents for the treatment and prevention of aids
AU6104896A (en) Therapeutic microdevices and methods of making and using sam e
AU5528996A (en) Methods of treating or preventing pain or nociception
AU6168296A (en) Chloroquine analogs and methods of preventing and treating p lasmodial disease
AU5984196A (en) Treatment and prevention of prostatic disease
AU4816896A (en) Treatment and prevention of prostatic cancer
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU6829696A (en) Treatment of solutions
AU4546096A (en) Treatment of waste
EP0800396A4 (en) Treatment of hyperandrogenic conditions
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease
AU1408999A (en) Detection and treatment of retinal degenerative disease
AU6038196A (en) Compositions and methods of treating il-6 associated disease s
GB9516572D0 (en) Prevention and/or treatment of disease
AU3762397A (en) Treatment and prevention of helicobacter infection
AU1931895A (en) Treatment of graft-versus-host disease
AU6852896A (en) Diagnosis and treatment of neurological disease
AU2003203740A1 (en) Prevention and treatment of amyloidogenic disease
AU2609195A (en) Treatment and prevention of helicobacter infection
PL342649A1 (en) Prevention of amyloidogenous diseases and treatment of them